Other peptides

Shop By
View as List Grid

Items 1-12 of 17

Set Descending Direction
  1. PrRP-(24-31) (human), Agonist of PrRP receptor
    SMILES: CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
    InChIKey: JPKRCQSTRQEKSF-GFYOBVKKSA-N
    InChI: InChI=1S/C41H68N14O9/c1-5-24(4)33(53-30(56)21-42)37(61)51-27(15-10-18-48-41(45)46)38(62)55-19-11-16-29(55)35(59)54-32(23(2)3)36(60)49-22-31(57)50-26(14-9-17-47-40(43)44)34(58)52-28(39(63)64)20-25-12-7-6-8-13-25/h6-8,12-13,23-24,26-29,32-33H,5,9-11,14-22,42H2,1-4H3,(H,49,60)(H,50,57)(H,51,61)(H,52,58)(H,53,56)(H,54,59)(H,63,64)(H4,43,44,47)(H4,45,46,48)/t24-,26-,27-,28-,29-,32-,33-/m0/s1
    Synonyms: human prolactin-releasing peptide-24-31
  2. Thr¹⁰contulakin-G, Agonist of NTS 1 receptor;Agonist of NTS 2 receptor
    SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O
    InChIKey: RMBUSFDUDIVELV-FEHLDFIESA-N
    InChI: InChI=1S/C74H117N19O27/c1-7-37(4)59(71(116)89-49(74(119)120)29-36(2)3)91-67(112)47(30-40-16-18-41(97)19-17-40)88-70(115)52-15-12-28-93(52)73(118)46(14-9-11-27-76)86-63(108)42(13-8-10-26-75)85-72(117)60(39(6)96)92-61(106)38(5)80-66(111)48(31-53(77)98)87-68(113)50(34-94)82-56(101)33-78-55(100)32-79-62(107)43(21-24-57(102)103)83-65(110)45(22-25-58(104)105)84-69(114)51(35-95)90-64(109)44-20-23-54(99)81-44/h16-19,36-39,42-52,59-60,94-97H,7-15,20-35,75-76H2,1-6H3,(H2,77,98)(H,78,100)(H,79,107)(H,80,111)(H,81,99)(H,82,101)(H,83,110)(H,84,114)(H,85,117)(H,86,108)(H,87,113)(H,88,115)(H,89,116)(H,90,109)(H,91,112)(H,92,106)(H,102,103)(H,104,105)(H,119,120)/t37-,38-,39+,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,59-,60-/m0/s1
  3. [Tyr³⁴]GLP-2 (human), Agonist of GLP-2 receptor
    SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC
    InChIKey: QUAPABCMPINESI-FSOLLKKFSA-N
    InChI: InChI=1S/C174H263N45O57S/c1-22-82(11)134(166(268)196-103(49-51-123(177)226)150(252)217-138(89(18)222)170(272)195-101(43-34-35-54-175)149(251)213-137(85(14)25-4)169(271)219-139(90(19)223)171(273)210-119(72-133(241)242)160(262)211-120(173(275)276)62-94-45-47-97(225)48-46-94)214-161(263)108(59-81(9)10)199-154(256)111(63-95-73-185-100-42-33-32-41-98(95)100)202-156(258)113(66-125(179)228)209-167(269)135(83(12)23-2)215-162(264)110(61-93-39-30-27-31-40-93)200-158(260)117(70-131(237)238)205-146(248)102(44-36-55-184-174(181)182)192-142(244)87(16)188-141(243)86(15)190-151(253)106(57-79(5)6)198-155(257)112(65-124(178)227)204-159(261)118(71-132(239)240)206-152(254)107(58-80(7)8)208-168(270)136(84(13)24-3)216-172(274)140(91(20)224)218-163(265)114(67-126(180)229)203-148(250)105(53-56-277-21)194-147(249)104(50-52-128(231)232)193-157(259)116(69-130(235)236)207-165(267)122(77-221)212-153(255)109(60-92-37-28-26-29-38-92)201-164(266)121(76-220)191-127(230)75-186-145(247)115(68-129(233)234)197-143(245)88(17)189-144(246)99(176)64-96-74-183-78-187-96/h26-33,37-42,45-48,73-74,78-91,99,101-122,134-140,185,220-225H,22-25,34-36,43-44,49-72,75-77,175-176H2,1-21H3,(H2,177,226)(H2,178,227)(H2,179,228)(H2,180,229)(H,183,187)(H,186,247)(H,188,243)(H,189,246)(H,190,253)(H,191,230)(H,192,244)(H,193,259)(H,194,249)(H,195,272)(H,196,268)(H,197,245)(H,198,257)(H,199,256)(H,200,260)(H,201,266)(H,202,258)(H,203,250)(H,204,261)(H,205,248)(H,206,254)(H,207,267)(H,208,270)(H,209,269)(H,210,273)(H,211,262)(H,212,255)(H,213,251)(H,214,263)(H,215,264)(H,216,274)(H,217,252)(H,218,265)(H,219,271)(H,231,232)(H,233,234)(H,235,236)(H,237,238)(H,239,240)(H,241,242)(H,275,276)(H4,181,182,184)/t82-,83-,84-,85-,86-,87-,88-,89+,90+,91+,99-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,134-,135-,136-,137-,138-,139-,140-/m0/s1
    Synonyms: human [Tyr³⁴] glucagon-like peptide 2
  4. [¹²⁵I]neurotensin (human, mouse, rat), Agonist of NTS 1 receptor;Agonist of NTS 2 receptor
    SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)O
    InChIKey: PCJGZPGTCUMMOT-ISULXFBGSA-N
    InChI: InChI=1S/C78H121N21O20/c1-7-43(6)63(73(115)96-57(76(118)119)37-42(4)5)97-70(112)55(39-45-21-25-47(101)26-22-45)95-72(114)59-18-13-35-99(59)75(117)52(16-11-33-86-78(83)84)90-64(106)48(15-10-32-85-77(81)82)89-71(113)58-17-12-34-98(58)74(116)51(14-8-9-31-79)91-69(111)56(40-60(80)102)94-66(108)50(28-30-62(104)105)88-68(110)54(38-44-19-23-46(100)24-20-44)93-67(109)53(36-41(2)3)92-65(107)49-27-29-61(103)87-49/h19-26,41-43,48-59,63,100-101H,7-18,27-40,79H2,1-6H3,(H2,80,102)(H,87,103)(H,88,110)(H,89,113)(H,90,106)(H,91,111)(H,92,107)(H,93,109)(H,94,108)(H,95,114)(H,96,115)(H,97,112)(H,104,105)(H,118,119)(H4,81,82,85)(H4,83,84,86)/t43-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,63-/m0/s1
  5. contulakin-G, Agonist of NTS 1 receptor;Agonist of NTS 2 receptor
    Cas#: 229180-41-0        Compound CID:  156599391
    SMILES: CCC(C)[C@@H](C(=O)NC(CC(C)C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]3CCC(=O)N3
  6. teduglutide, Agonist of GLP-2 receptor
    Cas#: 197922-42-2        Compound CID:  16139605
    SMILES: CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](Cc1cnc[nH]1)N
    InChIKey: CILIXQOJUNDIDU-ASQIGDHWSA-N
    InChI: InChI=1S/C164H252N44O55S/c1-21-77(11)126(156(255)187-95(44-46-114(167)214)141(240)206-130(83(17)211)160(259)186-93(42-33-34-49-165)140(239)202-129(80(14)24-4)159(258)208-131(84(18)212)161(260)200-111(163(262)263)66-125(230)231)203-151(250)100(54-76(9)10)189-145(244)103(57-88-67-175-92-41-32-31-40-90(88)92)192-147(246)105(60-116(169)216)199-157(256)127(78(12)22-2)204-152(251)102(56-87-38-29-26-30-39-87)190-149(248)109(64-123(226)227)195-137(236)94(43-35-50-174-164(171)172)183-134(233)82(16)179-133(232)81(15)180-142(241)98(52-74(5)6)188-146(245)104(59-115(168)215)194-150(249)110(65-124(228)229)196-143(242)99(53-75(7)8)198-158(257)128(79(13)23-3)205-162(261)132(85(19)213)207-153(252)106(61-117(170)217)193-139(238)97(48-51-264-20)185-138(237)96(45-47-120(220)221)184-148(247)108(63-122(224)225)197-155(254)113(72-210)201-144(243)101(55-86-36-27-25-28-37-86)191-154(253)112(71-209)182-119(219)70-177-136(235)107(62-121(222)223)181-118(218)69-176-135(234)91(166)58-89-68-173-73-178-89/h25-32,36-41,67-68,73-85,91,93-113,126-132,175,209-213H,21-24,33-35,42-66,69-72,165-166H2,1-20H3,(H2,167,214)(H2,168,215)(H2,169,216)(H2,170,217)(H,173,178)(H,176,234)(H,177,235)(H,179,232)(H,180,241)(H,181,218)(H,182,219)(H,183,233)(H,184,247)(H,185,237)(H,186,259)(H,187,255)(H,188,245)(H,189,244)(H,190,248)(H,191,253)(H,192,246)(H,193,238)(H,194,249)(H,195,236)(H,196,242)(H,197,254)(H,198,257)(H,199,256)(H,200,260)(H,201,243)(H,202,239)(H,203,250)(H,204,251)(H,205,261)(H,206,240)(H,207,252)(H,208,258)(H,220,221)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H,262,263)(H4,171,172,174)/t77-,78-,79-,80-,81-,82-,83+,84+,85+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,126-,127-,128-,129-,130-,131-,132-/m0/s1
    Synonyms: s9935 | revefenacinum | HOVEYDA-GRUBBS CATALYST M72 | GLP2-2G | (Gly2)GLP-2 | teduglutidum | [Gly2]GLP-2 | Teduglutid...
  7. GLP-2-(1-29) (rat), Agonist of GLP-2 receptor
    SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)CC
    InChIKey: HWWYRXSEACCADD-IUWMYHKYSA-N
    InChI: InChI=1S/C146H221N39O49S/c1-19-68(10)112(140(228)165-84(38-40-102(148)191)125(213)185-117(75(17)190)145(233)234)180-135(223)89(47-67(8)9)168-129(217)92(50-78-59-156-82-36-29-28-35-80(78)82)171-131(219)94(53-104(150)193)178-141(229)113(69(11)20-2)181-136(224)91(49-77-33-26-23-27-34-77)169-133(221)98(57-110(202)203)174-122(210)83(37-30-43-155-146(152)153)164-143(231)115(73(15)188)183-119(207)72(14)160-126(214)87(45-65(4)5)167-130(218)93(52-103(149)192)173-134(222)99(58-111(204)205)175-127(215)88(46-66(6)7)177-142(230)114(70(12)21-3)182-144(232)116(74(16)189)184-137(225)95(54-105(151)194)172-124(212)86(42-44-235-18)163-123(211)85(39-41-107(196)197)162-132(220)97(56-109(200)201)176-139(227)101(63-187)179-128(216)90(48-76-31-24-22-25-32-76)170-138(226)100(62-186)161-106(195)61-157-121(209)96(55-108(198)199)166-118(206)71(13)159-120(208)81(147)51-79-60-154-64-158-79/h22-29,31-36,59-60,64-75,81,83-101,112-117,156,186-190H,19-21,30,37-58,61-63,147H2,1-18H3,(H2,148,191)(H2,149,192)(H2,150,193)(H2,151,194)(H,154,158)(H,157,209)(H,159,208)(H,160,214)(H,161,195)(H,162,220)(H,163,211)(H,164,231)(H,165,228)(H,166,206)(H,167,218)(H,168,217)(H,169,221)(H,170,226)(H,171,219)(H,172,212)(H,173,222)(H,174,210)(H,175,215)(H,176,227)(H,177,230)(H,178,229)(H,179,216)(H,180,223)(H,181,224)(H,182,232)(H,183,207)(H,184,225)(H,185,213)(H,196,197)(H,198,199)(H,200,201)(H,202,203)(H,204,205)(H,233,234)(H4,152,153,155)/t68-,69-,70-,71-,72-,73+,74+,75+,81-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,112-,113-,114-,115-,116-,117-/m0/s1
  8. JMV458, Agonist of NTS 1 receptor;Agonist of NTS 2 receptor
    Cas#: 153723-53-6        Compound CID:  5311320
    IUPAC Name: (2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid
    SMILES: CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)O)CC(C)C)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)CCCN=C(N)N)CCCN=C(N)N)C
    InChIKey: KOHSYJYVCLITLX-OLPQHFNPSA-N
    InChI: InChI=1S/C45H73N13O9/c1-8-26(4)35(39(62)55-33(41(64)65)22-25(2)3)57-37(60)32(23-27-24-52-29-15-10-9-14-28(27)29)54-38(61)34-18-13-21-58(34)40(63)31(17-12-20-51-43(48)49)53-36(59)30(16-11-19-50-42(46)47)56-44(66)67-45(5,6)7/h9-10,14-15,24-26,30-35,52H,8,11-13,16-23H2,1-7H3,(H,53,59)(H,54,61)(H,55,62)(H,56,66)(H,57,60)(H,64,65)(H4,46,47,50)(H4,48,49,51)/t26-,30-,31-,32-,33-,34-,35-/m0/s1
    Synonyms: JMV 458;JMV-458
Page
per page

Looking for the right experience?



We noticed your location and want to make sure you’re viewing the most relevant version of our site.
Would you like to be redirected to your local region’s page for a smoother experience?